A review of vedolizumab and ustekinumab for the treatment of inflammatory bowel diseases

por Shim, Hang Hock, Chan, Pak Wo, Chuah, Sai Wei, Schwender, Brian J, Kong, San Choon, Ling, Khoon Lin
Publicado 2018

Perceptions of non-alcoholic fatty liver disease – an Asian community-based study

por Goh, George B.B., Kwan, Clarence, Lim, Sze Ying, Venkatanarasimha, Nanda KK, Abu-Bakar, Rafidah, Krishnamoorthy, Thinesh L, Shim, Hang Hock, Tay, Kiang Hiong, Chow, Wan Cheng
Publicado 2016

The Role of Bowel Ultrasound in Detecting Subclinical Inflammation in Pregnant Women with Crohn’s Disease

por Leung, Yvette, Shim, Hang Hock, Wilkens, Rune, Tanyingoh, Divine, Afshar, Elnaz Ehteshami, Sharifi, Nastaran, Pauls, Mehrnoosh, Novak, Kerri L, Kaplan, Gilaad G, Panaccione, Remo, Wilson, Stephanie R, Seow, Cynthia H
Publicado 2019

Preoperative Ustekinumab Treatment Is Not Associated With Increased Postoperative Complications in Crohn’s Disease: A Canadian Multi-Centre Observational Cohort Study

por Shim, Hang Hock, Ma, Christopher, Kotze, Paulo G, Seow, Cynthia H, Al-Farhan, Heba, Al-Darmaki, Ahmed K, Pang, Jack X Q, Fedorak, Richard N, Devlin, Shane M, Dieleman, Levinus A, Kaplan, Gilaad G, Novak, Kerri L, Kroeker, Karen I, Halloran, Brendan P, Panaccione, Remo
Publicado 2018